Reimagining our Canadian Potential: Working Together through Partnerships and Collaborations
October 23-24, 2023
MaRS Discovery District (Toronto) 101 College Street
Registration & Breakfast – Concourse Level Auditorium 7:00am
opening remarks at 8:30am
IMPORTANT NOTICE
*** Please note that our email address has changed to admin@capt-actp.ca ***
Click HERE to Access Conference Program
Recordings:
Slides:
- October 23, 2023
- From Guidance to real-world application: How can we continue to better use RWD in HTA decision-making?
- Drug shortages
- Prioritizing eye health for Canadians and system readiness
- How value-based healthcare can be applied to improve evaluation and funding decisions in rare diseases and cancer, drawing on global examples and emerging best practices in Canada
- Supporting innovative therapeutics for dementia treatment and beyond
- Oral Presentations of top-ranked research abstracts
- October 24, 2023
- Early Morning Workshop: Propensity Scores – From lingo to applications in real world evidence
- Rare Disease Strategy – Evolution, Needs and Future Steps
- Exploring diverse approaches to health technology assessment and reimbursement for cancer therapies: Can new Canadian collaborations help enable timely access?
- Public payer best practices for providing timely patient access to cancer therapies
Click HERE to Access Abstract Booklet
2023 Student Award Recipients
Dr. E. Keith Borden Award for Students
- Best Oral Presentation – Naomi Chouinard
- “Comparing approaches to determine the costs of treating burn victims in Quebec”
- Best Poster Presentation – Lauren Tailor
- “ASA prophylaxis for preeclampsia prevention: validation within a large administrative dataset“
CAPT-ACTP Proudly Recognizes and Thanks Our 2023 Partners
Platinum
AbbVie
Apellis
Eisai
Hoffmann-La Roche
IMC
IQVIA
Merck
Pfizer
Gold
AstraZeneca
Eversana
Silver
Amgen
Bayer
Innomar Stratagies
Novartis
PDCI
Bronze
Astellas
CADTH
CSL Behring
HOPE Research
Sanofi